In the world of investing, dividend stocks have long been a beacon of hope for those seeking steady wealth accumulation. The data is clear: over the past five decades, dividend growers and initiators have outperformed their peers, with an average annual total return of 10.22%, compared to just 6.87% for those with no change in dividend policy. This trend is a testament to the power of dividends, and today, we delve into three stocks that are poised to deliver substantial returns for investors. Firstly, Pfizer (PFE) stands out as a pharmaceutical powerhouse with a robust dividend yield of 6.7%. This yield is a result of the stock's recent losses, which have pushed its price down, thereby increasing its dividend yield. Despite patent protection expirations affecting its biggest sellers, Pfizer is strategically addressing this challenge by developing a promising pipeline of drugs and acquiring promising assets from other companies. The stock's forward P/E ratio of 9.0 is also well below its five-year average of 9.7, indicating that it may be undervalued. Secondly, United Parcel Service (UPS) is another dividend giant with a massive 7.7% yield. Despite posting average annual losses over the past three years, UPS is making strategic moves to boost its profitability. The company's decision to cut back on deliveries for Amazon.com (AMZN) has raised eyebrows, but it's a calculated move to focus on higher-margin customers, such as small and medium-sized businesses and the healthcare sector. The first-quarter report showed a 2.3% decline in overall domestic revenue, but a 6.5% growth in revenue per package, with international revenue rising by 3.8% and revenue per package soaring by 12.1%. The forward P/E ratio of 14 is slightly below the five-year average of 15, making UPS an attractive long-term investment. Lastly, the Schwab U.S. Dividend Equity ETF (SCHD) is an exchange-traded fund that offers a compelling blend of income and growth. With a yield of 3.25% and a diverse portfolio of approximately 100 dividend-paying stocks, including Qualcomm (QCOM), Texas Instruments (TXN), and UnitedHealth Group (UNH), SCHD provides investors with a well-rounded approach to dividend investing. The ETF has outperformed the market, with a nearly 20% year-to-date return as of June 4, making it a strong addition to any investment portfolio. In conclusion, these three dividend stocks offer a compelling opportunity for investors to boost their wealth over time. Pfizer's undervalued stock, UPS's strategic focus on higher-margin customers, and the Schwab U.S. Dividend Equity ETF's diverse and profitable portfolio make them attractive choices for those seeking steady returns and long-term wealth accumulation.
